Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene

[1]  D. Cooper,et al.  Human Gene Mutation Database , 1996, Human Genetics.

[2]  N. Tusneem,et al.  Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles , 1996, Molecular and cellular biology.

[3]  D. Rodenhiser,et al.  Site and sequence specific DNA methylation in the neurofibromatosis (NF1) gene includes C5839T: the site of the recurrent substitution mutation in exon 31. , 1996, Human molecular genetics.

[4]  P S Harper,et al.  Molecular genetics of neurofibromatosis type 1 (NF1). , 1996, Journal of medical genetics.

[5]  N. Copeland,et al.  Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons , 1995, Cell.

[6]  S. Huson,et al.  Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene. , 1995, Journal of medical genetics.

[7]  J. Declue,et al.  Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. , 1995, Oncogene.

[8]  R. Heim,et al.  Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. , 1995, Human molecular genetics.

[9]  S. Purandare,et al.  Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. , 1994, Human molecular genetics.

[10]  F. Tamanoi,et al.  Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes , 1994, Molecular and cellular biology.

[11]  D. Easton,et al.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. , 1993, American journal of human genetics.

[12]  M. Wigler,et al.  Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis. , 1993, Oncogene.

[13]  F. Collins,et al.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients , 1992, Nature.

[14]  R. Cawthon,et al.  Somatic mutations in the neurofibromatosis 1 gene in human tumors , 1992, Cell.

[15]  M. Daston,et al.  The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes , 1992, Neuron.

[16]  M. Boguski,et al.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. , 1991, Genomics.

[17]  F. Tamanoi,et al.  The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae , 1990, Cell.

[18]  M. Wigler,et al.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.

[19]  P. O’Connell,et al.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 , 1990, Cell.

[20]  N. Copeland,et al.  Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway , 1990, Nature.

[21]  V. M. Riccardi,et al.  Von Recklinghausen neurofibromatosis. , 1981, The New England journal of medicine.

[22]  F. Collins,et al.  Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis , 1993, Nature Genetics.

[23]  A. Look,et al.  Cell transformation by ras and regulation of its protein product. , 1993, Ciba Foundation symposium.